These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Development of ophthalmic pathology and precision medicine]. Li YP; Li B Zhonghua Yan Ke Za Zhi; 2016 Oct; 52(10):724-727. PubMed ID: 27760643 [TBL] [Abstract][Full Text] [Related]
24. [Personalized medicine in oncology]. Lörsch AM; Jung J; Lange S; Pfarr N; Mogler C; Illert AL Pathologie (Heidelb); 2024 May; 45(3):180-189. PubMed ID: 38568256 [TBL] [Abstract][Full Text] [Related]
25. The Jules François Memorial lecture. The collaborative ocular melanoma study and management of choroidal melanoma. Straatsma BR Bull Soc Belge Ophtalmol; 2002; (283):5-11. PubMed ID: 12058487 [No Abstract] [Full Text] [Related]
26. [Seventy years of development and prospects of the ocular oncology specialty in China]. Fan XQ; Jia RB Zhonghua Yan Ke Za Zhi; 2020 Sep; 56(9):646-652. PubMed ID: 32907298 [TBL] [Abstract][Full Text] [Related]
27. Cancer in the Elderly: Moving the Needle Toward Evidence-Based Personalized Oncology. Extermann M Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):718-720. PubMed ID: 28602406 [No Abstract] [Full Text] [Related]
28. Ocular oncology research: the advance of patient care and science. Grossniklaus HE; Straatsma BR Am J Ophthalmol; 2002 Jan; 133(1):129-30. PubMed ID: 11755848 [No Abstract] [Full Text] [Related]
29. Welcome to the 16th volume of Jenkins R; Gautier L Future Oncol; 2020 Jan; 16(1):4247-4250. PubMed ID: 31797678 [No Abstract] [Full Text] [Related]
30. [Emphasis on the application of precision medicine in ophthalmology]. Sun XD; Zhu H Zhonghua Yan Ke Za Zhi; 2016 Feb; 52(2):85-8. PubMed ID: 26906701 [TBL] [Abstract][Full Text] [Related]
31. [Personalized medicine in the treatment of eye tumors : Connection between molecular biology, clinical aspects and personal needs of patients]. Kakkassery V Ophthalmologe; 2020 Jun; 117(6):497-498. PubMed ID: 32002620 [No Abstract] [Full Text] [Related]
32. Precision medicine strategies in oncology: mixed approaches to matched therapies. Borcoman E; Le Tourneau C Future Oncol; 2018 Jan; 14(2):105-109. PubMed ID: 29224361 [No Abstract] [Full Text] [Related]
33. Clinical trials in the era of personalized oncology. Maitland ML; Schilsky RL CA Cancer J Clin; 2011; 61(6):365-81. PubMed ID: 22034206 [TBL] [Abstract][Full Text] [Related]
35. The future of oncology therapeutics. Mansinho A; Boni V; de Miguel M; Calvo E Expert Rev Anticancer Ther; 2017 Jul; 17(7):563-565. PubMed ID: 28504011 [No Abstract] [Full Text] [Related]
37. Ocular oncology in India. Khetan V Indian J Ophthalmol; 2015 Feb; 63(2):177. PubMed ID: 25850417 [No Abstract] [Full Text] [Related]
38. Management of primary intraocular lymphoma. Kim SK; Chan CC; Wallace DJ Curr Oncol Rep; 2005 Jan; 7(1):74-9. PubMed ID: 15610690 [TBL] [Abstract][Full Text] [Related]
39. [Ophthalmology in 2016 : the advent of ocular biomarkers]. Matet A; Daruich A; Behar-Cohen F Rev Med Suisse; 2017 Jan; 13(544-545):84-87. PubMed ID: 28703544 [TBL] [Abstract][Full Text] [Related]
40. Personalized integrative oncology: targeted approaches for optimal outcomes: the 11th International Conference of the Society for Integrative Oncology. Lee RT; Yang P; Greenlee H; Bauer-Wu S; Balneaves LG; Zick S Integr Cancer Ther; 2015 Jan; 14(1):98-105. PubMed ID: 25505022 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]